Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-04-26
2009-06-16
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S346000
Reexamination Certificate
active
07547699
ABSTRACT:
The present invention refers to chemical compounds of formula (I)as well as pharmaceutically acceptable salts and esters thereof, wherein R1to R5have the significance given in claim 1. These compounds can be used for the preparation of medicaments.
REFERENCES:
patent: 4598089 (1986-07-01), Hadvary et al.
patent: 4931463 (1990-06-01), Barbier et al.
patent: 4983746 (1991-01-01), Barbier et al.
patent: 5175186 (1992-12-01), Barbier et al.
patent: 5245056 (1993-09-01), Karph et al.
patent: 5246960 (1993-09-01), Barbier et al.
patent: 5399720 (1995-03-01), Karpf et al.
patent: 6004996 (1999-12-01), Shah et al.
patent: 189577 (1989-12-01), None
patent: 185359 (1991-12-01), None
patent: 524495 (1996-10-01), None
patent: 443449 (1997-05-01), None
patent: WO99/34786 (1999-07-01), None
patent: WO 00/09122 (2000-02-01), None
patent: WO 00/09123 (2000-02-01), None
patent: WO 00/12510 (2000-03-01), None
patent: WO 00/44753 (2000-08-01), None
patent: WO 02/10169 (2002-02-01), None
patent: WO 03064423 (2003-08-01), None
patent: WO 2005000849 (2005-01-01), None
Keller and Wahli: Trends Endocrin. Metab. 1993; 4: 291-296.
Macdonald and Lane: Current Biology vol. 5 pp. 618-621 (1995).
D. Hoyer, G. Engel and H.O. Kalkman,European J. Pharmacol.,1985, 118, 13-23.
K. Schmuck, C. Ullmer, P. Engels and H. Lubbert,FEBS Lett.,1994, 342, 85-90.
D. J. McKenna and S. J. Peroutka,J. Neurosci.,1989, 9, 3482-90.
Hebeisen Paul
Monck Nathaniel
Richter Hans
Roever Stephan
Hoffmann-La Roche Inc.
Johnston George W.
McDowell Brian
Megerditchian Samuel H.
Tramaloni Dennis P.
LandOfFree
Tetracyclic 6 azapyrazinoindolines as 5HT2C receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetracyclic 6 azapyrazinoindolines as 5HT2C receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetracyclic 6 azapyrazinoindolines as 5HT2C receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4146663